Ftse Mib
34.490,71
0,07%
DAX
18.693,37
0,04%
S&P 500
5.304,72
0,70%
NASDAQ
16.920,79
1,10%
Bitcoin
68.756,79
0,33%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Gamida Cell Ltd (GMDA) Gamida Cell Ltd (GMDA) Notizie

GMDA

Gamida Cell (GMDA)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:GMDA
DataOraFonteTitoloSimboloCompagnia
08/04/202413:30GlobeNewswire Inc.XORTX Welcomes New Member to the Board of DirectorsNASDAQ:GMDAGamida Cell Ltd
01/04/202414:00GlobeNewswire Inc.Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech ExecutiveNASDAQ:GMDAGamida Cell Ltd
27/03/202411:57IH Market NewsU.S. Stock Index Futures Point to a Rebound, Oil See Declines in Early TradingNASDAQ:GMDAGamida Cell Ltd
14/02/202420:14Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GMDAGamida Cell Ltd
02/02/202422:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GMDAGamida Cell Ltd
29/01/202412:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GMDAGamida Cell Ltd
15/12/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GMDAGamida Cell Ltd
06/12/202323:24Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:GMDAGamida Cell Ltd
20/11/202323:27Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:GMDAGamida Cell Ltd
15/11/202323:24Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:GMDAGamida Cell Ltd
14/11/202313:00GlobeNewswire Inc.Gamida Cell Reports Third Quarter 2023 Financial Results and Provides Company UpdateNASDAQ:GMDAGamida Cell Ltd
20/10/202322:39Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:GMDAGamida Cell Ltd
11/10/202313:07Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:GMDAGamida Cell Ltd
13/09/202322:01Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:GMDAGamida Cell Ltd
01/09/202322:08Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:GMDAGamida Cell Ltd
21/08/202323:00Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:GMDAGamida Cell Ltd
15/08/202322:11Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:GMDAGamida Cell Ltd
14/08/202322:19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GMDAGamida Cell Ltd
11/07/202314:00Business WireData Published in Transplantation and Cellular Therapy Suggest Antiviral Protection After Transplantation with Gamida Cell’s Omisirge® (omidubicel-onlv)NASDAQ:GMDAGamida Cell Ltd
10/07/202320:00PR Newswire (US)STAND UP TO CANCER NAMES JULIAN ADAMS, Ph.D., CHIEF SCIENCE OFFICERNASDAQ:GMDAGamida Cell Ltd
14/06/202322:30Business WireGamida Cell To Host Investor DayNASDAQ:GMDAGamida Cell Ltd
31/05/202322:30Business WireGamida Cell to Present Corporate Highlights at the Jefferies Healthcare ConferenceNASDAQ:GMDAGamida Cell Ltd
31/05/202313:00Business WireData To Be Presented on Gamida Cell Natural Killer (NK) Cell Therapy Candidate GDA-201 at the International Society for Cell & Gene Therapy 2023 Annual MeetingNASDAQ:GMDAGamida Cell Ltd
26/05/202322:20Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:GMDAGamida Cell Ltd
25/05/202322:14Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:GMDAGamida Cell Ltd
22/05/202314:00Business WireGamida Cell Appoints Terry Coelho as CFONASDAQ:GMDAGamida Cell Ltd
16/05/202322:02Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:GMDAGamida Cell Ltd
15/05/202323:14Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GMDAGamida Cell Ltd
15/05/202322:05Business WireGamida Cell Reports First Quarter 2023 Financial Results and Provides Company UpdateNASDAQ:GMDAGamida Cell Ltd
11/05/202323:20Business WireGamida Cell Announces the Date of Its First Quarter 2023 Financial Results and WebcastNASDAQ:GMDAGamida Cell Ltd
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:GMDA

La tua Cronologia

COIN
CRMSNBTC
COIN
FINTETH
FINT
BOV
CSNAG131
CSNAG131 Ex:12,44
LSE
XLPE
X Priv Eqty Sw
BIT
F17515
Vontobel Financial Produ...
EU
AFDEX
Agence Francaise de Deve...
USOTC
MTHRF
M3 KK (PK)
DGFX
GIBBTC
Bible
GATE
CREUSDT
CarryToken
USOTC
NXSL
Nextech Solutions (CE)
LBNK
NUGENUSDT
NUGEN
BMF
DIIN24F26
DIIN24F26 - 07/2024
LSE
AG17
Citi Fun 25
NYSE
ATAQ.U
Altimar Acquisition Corp...
COIN
STRUST
Stater
COIN
XRTETH
Robonomics
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network